Doug Ethell

Doug Ethell

Company: Leucadia Therapeutics

Job title: Chief Executive Officer

Seminars:

Treating Alzheimer’s Disease by Draining Detritus from the Brain 3:15 pm

Using artificial intelligence to show that aging reduces the brain’s clearance of metabolites Explaining the effects of an implantable device which restores the clearance mechanism Reviewing preparation for clinical trials of the Arethusta device which begins in 2023Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.